ArticlePloS one2024

Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.

Tetsuzo Tauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.